Validation of a Dried Blood Spot Method to Measure Tacrolimus Concentrations in Small Volumes of Mouse Blood

References

• Brunet M , van GelderT, ÅsbergAet al. Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report. Ther. Drug Monit.41(3), 261–307 (2019).
   PubMed Web of Science ®Google Scholar
• Emal D , RampanelliE, ClaessenNet al. Calcineurin inhibitor tacrolimus impairs host immune response against urinary tract infection. Sci. Rep.9(1), 1–11 (2019).
   PubMedGoogle Scholar
• Abidi MZ , ErlandsonKM. A comprehensive review of infections in older kidney transplant recipients. Curr. Transplant. Rep.8, 90–99 (2021).
   Google Scholar
• Randhawa PS , StarzlTE, DemetrisAJ. Tacrolimus (FK506)-associated renal pathology. Adv. Anat. Pathol.4(4), 265 (1997).
   PubMedGoogle Scholar
• Hošková L , MálekI, KopkanL, KautznerJ. Pathophysiological mechanisms of calcineurin inhibitor-induced nephrotoxicity and arterial hypertension. Physiol. Res.66(2), 167–180 (2017).
   PubMed Web of Science ®Google Scholar
• Moes A , HesselinkD, vanden Meiracker A, ZietseR, HoornE. Chlorthalidone versus amlodipine for hypertension in kidney transplant recipients treated with tacrolimus: a randomized crossover trial. Am. J. Kidney Dis.69(6), 796–804 (2017).
   PubMed Web of Science ®Google Scholar
• Shivaswamy V , BoernerB, LarsenJ. Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes. Endocr. Rev.37(1), 37–61 (2016).
   PubMed Web of Science ®Google Scholar
• Piotrowski PC , LutkowskaA, TsibulskiA, KarczewskiM, JagodzińskiPP. Neurologic complications in kidney transplant recipients. Folia Neuropathologica55(2), 86–109 (2017).
   PubMed Web of Science ®Google Scholar
• Diehl R , FerraraF, MüllerCet al. Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches. Cell. Mol. Immunol.14(2), 146–179 (2016).
   PubMed Web of Science ®Google Scholar
• Lee W-S , JeongJ-H, LeeE-Get al. Tacrolimus regulates endoplasmic reticulum stress-mediated osteoclastogenesis and inflammation: in vitro and collagen-induced arthritis mouse model. Cell Biol. Int.42(4), 393–402 (2018).
   PubMed Web of Science ®Google Scholar
• Vandenbussche C , Vander Hauwaert C, DewaelesEet al. Tacrolimus-induced nephrotoxicity in mice is associated with microRNA deregulation. Arch. Toxicol.92(4), 1539–1550 (2018).
   PubMed Web of Science ®Google Scholar
• Kalt DA . Tacrolimus: a review of laboratory detection methods and indications for use. Lab. Med.48(4), e62–e65 (2017).
   PubMed Web of Science ®Google Scholar
• Diehl KH , HullR, MortonDet al. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J. Appl. Toxicol.21(1), 15–23 (2001).
   PubMed Web of Science ®Google Scholar
• van Zuthphen LFM , BaumansV, BeynenAC. Principles of Laboratory Animal Science revised edition.Elsevier, Amsterdam, The Netherlands, ISBN: 9780444506122 (2001).
   Google Scholar
• Van Amsterdam P , WaldropC. The application of dried blood spot sampling in global clinical trials. Bioanalysis2(11), 1783–1786 (2010).
   PubMed Web of Science ®Google Scholar
• Koster RA , GreijdanusB, AlffenaarJWC, TouwDJ. Dried blood spot analysis of creatinine with LC–MS/MS in addition to immunosuppressants analysis. Anal. Bioanal. Chem.407(6), 1585–1594 (2014).
   PubMed Web of Science ®Google Scholar
• Wickremsinhe ER , PerkinsEJ. Using dried blood spot sampling to improve data quality and reduce animal use in mouse pharmacokinetic studies. J. Ame. Assoc. Lab. Anim. Sci.54(2), 139–144 (2015).
   PubMed Web of Science ®Google Scholar
• Clark GT , HaynesJJ, BaylissMAJ, BurrowsL. Utilization of DBS within drug discovery: development of a serial microsampling pharmacokinetic study in mice. Bioanalysis2(8), 1477–1488 (2010).
   PubMed Web of Science ®Google Scholar
• Wong P , PhamR, WhitelyCet al. Application of automated serial blood sampling and dried blood spot technique with liquid chromatography–tandem mass spectrometry for pharmacokinetic studies in mice. J. Pharm. Biomed. Anal.56(3), 604–608 (2011).
   PubMed Web of Science ®Google Scholar
• Rahavendran SV , VekichS, SkorHet al. Discovery pharmacokinetic studies in mice using serial microsampling, dried blood spots and microbore LC–MS/MS. Bioanalysis4(9), 1077–1095 (2012).
   PubMed Web of Science ®Google Scholar
• van de Velde D , vander Graaf J, BoussaidiMet al. Development and validation of hematocrit level measurement in dried blood spots using near-infrared spectroscopy. Ther. Drug Monit.43(3), 351–357 (2021).
   PubMed Web of Science ®Google Scholar
• Capiau S , VeenhofH, KosterRAet al. Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: development and validation of dried blood spot-based methods for therapeutic drug monitoring. Ther. Drug Monit.41(4), 409–430 (2019).
   PubMed Web of Science ®Google Scholar
• Koster RA , VeenhofH, BotmaRet al. Dried blood spot validation of five immunosuppressants, without hematocrit correction, on two LC–MS/MS systems. Bioanalysis9(7), 553–563 (2017).
   PubMed Web of Science ®Google Scholar
• Martial LC , HoogtandersKEJ, SchreuderMFet al. Dried blood spot sampling for tacrolimus and mycophenolic acid in children: analytical and clinical validation. Ther. Drug Monit.39(4), 412–421 (2017).
   PubMed Web of Science ®Google Scholar
• Buchanan J , HolidayS, EverhartR, MileyM. Pressure and time. RivalSons (2011).
   Google Scholar
• den Burger JCG , WilhelmAJ, ChahbouniA, VosRM, SinjewelA, SwartEL. Analysis of cyclosporin A, tacrolimus, sirolimus, and everolimus in dried blood spot samples using liquid chromatography tandem mass spectrometry. Anal. Bioanal. Chem.404(6–7), 1803–1811 (2012).
   PubMed Web of Science ®Google Scholar
• Moretti M , FreniF, TomacielloIet al. Determination of benzodiazepines in blood and in dried blood spots collected from post-mortem samples and evaluation of the stability over a three-month period. Drug Test. Anal.11(9), 1403–1411 (2019).
   PubMed Web of Science ®Google Scholar
• Ghareeb M , AkhlaghiF. Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC–MS/MS. Bioanalysis7(8), 1037 (2015).
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services. Guidance for Industry, Bioanalytical Method Validation (2001). www.fda.gov/files/drugs/published/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf
   Google Scholar
• Balloch S , CaltonLJ, HammondG. Analysis of cyclosporine, everolimus, sirolimus, and tacrolimus in whole blood for clinical research. Application note. www.waters.com/nextgen/au/en/library/application-notes/2018/analysis-of-cyclosporine--everolimus--sirolimus--and-tacrolimus-.html
   Google Scholar
• European Medicines Agency. Bioanalytical method validation. www.ema.europa.eu/en/bioanalytical-method-validation
   Google Scholar
• Rangaraj N , VaghasiyaK, JaiswalS, SharmaA, LalJ. Do blood sampling sites affect pharmacokinetics?Chem. Biol. Interface4(3), 176–191 (2014).
   Google Scholar
• Chiou WL . The phenomenon and rationale of marked dependence of drug concentration on blood sampling site: implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (part II). Clin. Pharmacokinet.17(4), 275–290 (1989).
   PubMed Web of Science ®Google Scholar
• Koster RA , AlffenaarJWC, GreijdanusB, UgesDRA. Fast LC–MS/MS analysis of tacrolimus, sirolimus, everolimus and cyclosporin A in dried blood spots and the influence of the hematocrit and immunosuppressant concentration on recovery. Talanta115, 47–54 (2013).
   PubMed Web of Science ®Google Scholar